Jim Simons Oramed Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 151,808 shares of ORMP stock, worth $364,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,808

Previous 245,300 38.11%

Holding current value

$364,339

Previous $598,000 38.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$2.17 - $2.52 $202,877 - $235,599	-93,492 Reduced 38.11%	151,808 $367,000
Q3 2024 Nov 13, 2024	BUY	$2.21 - $2.63 $32,045 - $38,135	14,500 Added 6.28%	245,300 $598,000
Q2 2024 Aug 09, 2024	BUY	$2.07 - $2.83 $225,008 - $307,621	108,700 Added 89.03%	230,800 $593,000
Q1 2024 May 13, 2024	SELL	$2.18 - $3.58 $477,361 - $783,923	-218,973 Reduced 64.2%	122,100 $357,000
Q4 2023 Feb 13, 2024	BUY	$1.71 - $2.57 $507,481 - $762,706	296,773 Added 669.92%	341,073 $788,000
Q3 2023 Nov 14, 2023	BUY	$2.51 - $3.55 $26,605 - $37,630	10,600 Added 31.45%	44,300 $116,000
Q2 2023 Aug 11, 2023	BUY	$2.12 - $4.47 $46,216 - $97,446	21,800 Added 183.19%	33,700 $121,000
Q1 2023 May 12, 2023	BUY	$1.93 - $13.1 $22,967 - $155,890	11,900 New	11,900 $26,000
Q2 2022 Aug 12, 2022	BUY	$3.72 - $9.0 $1.34 Million - $3.24 Million	359,697 New	359,697 $1.65 Million
Q1 2022 May 13, 2022	SELL	$8.19 - $13.89 $1.66 Million - $2.82 Million	-203,200 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.98 - $29.75 $2.64 Million - $6.05 Million	203,200 New	203,200 $2.9 Million
Q1 2021 May 13, 2021	SELL	$4.22 - $11.33 $1.57 Million - $4.22 Million	-372,415 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$2.48 - $4.64 $238,576 - $446,367	-96,200 Reduced 20.53%	372,415 $1.58 Million
Q3 2020 Nov 13, 2020	BUY	$2.58 - $4.16 $630,294 - $1.02 Million	244,300 Added 108.91%	468,615 $1.22 Million
Q2 2020 Aug 13, 2020	BUY	$2.87 - $4.12 $103,033 - $147,908	35,900 Added 19.05%	224,315 $792,000
Q1 2020 May 14, 2020	SELL	$2.6 - $5.5 $102,206 - $216,205	-39,310 Reduced 17.26%	188,415 $573,000
Q4 2019 Feb 13, 2020	BUY	$2.43 - $5.74 $38,394 - $90,692	15,800 Added 7.46%	227,725 $1.17 Million
Q3 2019 Nov 13, 2019	BUY	$2.88 - $3.96 $155,021 - $213,154	53,827 Added 34.05%	211,925 $676,000
Q2 2019 Aug 12, 2019	BUY	$2.88 - $4.36 $152,763 - $231,267	53,043 Added 50.49%	158,098 $568,000
Q1 2019 May 14, 2019	BUY	$2.95 - $3.64 $137,254 - $169,358	46,527 Added 79.5%	105,055 $382,000
Q4 2018 Feb 13, 2019	BUY	$3.0 - $4.94 $175,584 - $289,128	58,528 New	58,528 $176,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

8.1M

Call Options Held

Put Options Held

18.1K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account